Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.

Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, Kalemkerian GP.

JAMA Oncol. 2017 Jun 1. doi: 10.1001/jamaoncol.2017.0982. [Epub ahead of print]

PMID:
28570742
2.

Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.

Oscherwitz J, Quinn CP, Cease KB.

Vaccine. 2015 May 11;33(20):2342-6. doi: 10.1016/j.vaccine.2015.03.037. Epub 2015 Mar 26.

3.

Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.

Oscherwitz J, Cease KB.

PLoS One. 2015 Jan 30;10(1):e0116882. doi: 10.1371/journal.pone.0116882. eCollection 2015.

4.

Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.

Oscherwitz J, Feldman D, Yu F, Cease KB.

Vaccine. 2015 Jan 9;33(3):430-6. doi: 10.1016/j.vaccine.2014.11.042. Epub 2014 Nov 30.

5.

In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.

Oscherwitz J, Muñoz-Planillo R, Yu F, Núñez G, Cease KB.

Mol Immunol. 2014 Jul;60(1):62-71. doi: 10.1016/j.molimm.2014.03.012. Epub 2014 Apr 24.

PMID:
24769493
6.

Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy.

Yuan ST, Brown RK, Zhao L, ten Haken RK, Gross M, Cease KB, Schipper M, Stanton P, Yu J, Kong FM.

Radiat Oncol. 2014 Jan 27;9(1):37. doi: 10.1186/1748-717X-9-37.

7.

Staphylococcus δ-toxin induces allergic skin disease by activating mast cells.

Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Muñoz-Planillo R, Hasegawa M, Villaruz AE, Cheung GY, McGavin MJ, Travers JB, Otto M, Inohara N, Núñez G.

Nature. 2013 Nov 21;503(7476):397-401. doi: 10.1038/nature12655. Epub 2013 Oct 30.

8.

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.

Ramnath N, Daignault-Newton S, Dy GK, Muindi JR, Adjei A, Elingrod VL, Kalemkerian GP, Cease KB, Stella PJ, Brenner DE, Troeschel S, Johnson CS, Trump DL.

Cancer Chemother Pharmacol. 2013 May;71(5):1173-82. doi: 10.1007/s00280-013-2109-x. Epub 2013 Feb 23.

9.

Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.

Oscherwitz J, Yu F, Jacobs JL, Cease KB.

Clin Vaccine Immunol. 2013 Mar;20(3):341-9. doi: 10.1128/CVI.00612-12. Epub 2013 Jan 2.

10.

Cancer Carepartners: Improving patients' symptom management by engaging informal caregivers.

Silveira MJ, Given CW, Cease KB, Sikorskii A, Given B, Northouse LL, Piette JD.

BMC Palliat Care. 2011 Nov 25;10:21. doi: 10.1186/1472-684X-10-21.

11.

A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.

Oscherwitz J, Yu F, Cease KB.

J Immunol. 2010 Sep 15;185(6):3661-8. doi: 10.4049/jimmunol.1001749. Epub 2010 Aug 9.

12.

A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo.

Oscherwitz J, Gribbin TE, Cease KB.

Mol Immunol. 2010 Apr;47(7-8):1484-91. doi: 10.1016/j.molimm.2010.01.026. Epub 2010 Feb 26.

PMID:
20189250
14.

Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.

Cai XW, Xu LY, Wang L, Hayman JA, Chang AC, Pickens A, Cease KB, Orringer MB, Kong FM.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1100-5. doi: 10.1016/j.ijrobp.2009.03.017. Epub 2009 Jun 18.

PMID:
19540063
15.

Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.

Oscherwitz J, Yu F, Jacobs JL, Liu TH, Johnson PR, Cease KB.

Infect Immun. 2009 Aug;77(8):3380-8. doi: 10.1128/IAI.00358-09. Epub 2009 Jun 1.

16.

Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors.

Liu TH, Oscherwitz J, Schnepp B, Jacobs J, Yu F, Cease KB, Johnson PR.

Mol Ther. 2009 Feb;17(2):373-9. doi: 10.1038/mt.2008.242. Epub 2008 Nov 11.

17.

The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.

Zhao L, Sheldon K, Chen M, Yin MS, Hayman JA, Kalemkerian GP, Arenberg D, Lyons SE, Curtis JL, Davis M, Cease KB, Brenner D, Anscher MS, Lawrence TS, Kong FM.

Lung Cancer. 2008 Feb;59(2):232-9. Epub 2007 Oct 1.

PMID:
17905467
18.

Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.

Oscherwitz J, Hankenson FC, Yu F, Cease KB.

Vaccine. 2006 Apr 5;24(15):3018-25. Epub 2005 Nov 8.

PMID:
16307832
19.

New insights and approaches regarding B- and T-cell epitopes in HIV vaccine design.

Oscherwitz J, Gotch FM, Cease KB, Berzofsky JA.

AIDS. 1999;13 Suppl A:S163-74. Review. No abstract available.

PMID:
10885773
20.

Supplemental Content

Loading ...
Support Center